A new measure of firm-level AI investments is proposed, using a unique combination of worker resume and job postings datasets, which reveals a stark increase in AI investments across sectors.
The Central Europe, Eastern Europe, and Central Asia region face the highest levels of CVD mortality globally, and the Sub-Saharan Africa region had the highest proportion of countries scoring two or less for the WHF Policy Index.
USAID funding has significantly contributed to the reduction in adult and child mortality across low-income and middle-income countries over the past two decades and, unless the abrupt funding cuts announced and implemented in the first half of 2025 are reversed, a staggering number of avoidable deaths could occur by 2030.
This study applies advanced machine learning techniques such as deep learning, regression models, and ensemble learning to improve forecasting accuracy aimed at achieving efficient resource allocation and investigates fault prediction in New Energy Vehicles and its implications for grid stability and energy demand management.
The empirical results show that the technology context (IT infrastructure and digital tools) along with the existing level of innovation are the main drivers that act as stepping stones in digital technology adoption.
This narrative review synthesizes current evidence regarding the global burden of periodontal disease, its established associations with systemic conditions including cardiovascular disease, diabetes, adverse pregnancy outcomes, respiratory infections, and neurodegenerative disorders, and its significant socioeconomic implications.
The economic burden of cardiovascular risk factors and overt cardiovascular disease in the United States is projected to increase substantially in the coming decades and development and deployment of cost-effective programs and policies to promote cardiovascular health are urgently needed to rein in costs and to equitably enhance population health.
It is shown that a rising Bitcoin price is followed by entry of new users, in particular among more risk-seeking segments of the population, and that when prices rise larger holders sell, likely making a return at retail users’ expense.
The mean cost of developing a new drug from 2000 to 2018 was $172.7 million but increased to $515.8 million when cost of failures was included and to $879.3 million when both drug development failure and capital costs were included.
Results from a series of nationally representative U.S. surveys of genAI use at work and at home suggest that work adoption of genAI has been faster than the personal computer (PC), and overall adoption has outpaced both PCs and the internet by an even wider margin.
The study identifies patterns among EU countries based on their digital technology adoption, innovation expenditures, and revenues and the proportion of enterprises engaged in innovation activities and highlights the central role of digital technologies in enhancing innovation and competitiveness.
It is found that few studies actually use AI to address normative or transformative dimensions of sustainability science, limiting the potential of relevant AI applications.
Article Galaxy Pages is a free service from Research Solutions, a company that offers access to content in collaboration with publishing partners, online repositories and discovery services.